Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ren Shen Yang Rong Tang is a traditional Chinese medicine formula composed of 14 herbal ingredients, originally formulated by Dr. Chen Yan during the Southern Song Dynasty and recorded in the "Treatise on Three Categories of Pathogenic Factors" in 1174 AD. The formula is a modification of Shi Quan Da Bu Tang (All Inclusive Great Tonifying Decoction) with additional herbs to nourish the Heart and calm the spirit. The formula's primary actions are to **tonify Qi and Blood** and **nourish the Heart**. It treats patterns of Qi and Blood deficiency, particularly when accompanied by instability of the Heart and spirit (Shen). The two principal ingredients are **Ginseng (Ren Shen)** and **White Peony Roots (Bai Shao)**, which work synergistically to address the pathodynamic and harmonize affected organs. **Complete ingredient list (14 herbs):** - Ginseng (Ren Shen) - king ingredient - White Peony Root (Bai Shao) - king ingredient - Atractylodes (Bai Zhu) - deputy ingredient - Astragalus (Huang Qi) - deputy ingredient - Angelica (Dang Gui) - deputy ingredient - Prepared Rehmannia Root (Shu Di Huang) - deputy ingredient - Poria (Fu Ling) - deputy ingredient - Licorice (Gan Cao) - deputy ingredient - Cinnamon Bark (Rou Gui) - assistant ingredient - Schisandra (Wu Wei Zi) - assistant ingredient - Polygala (Yuan Zhi) - assistant ingredient - Tangerine Peel (Chen Pi) - assistant ingredient - Two additional herbs not fully detailed in sources The formula exhibits **antioxidant and anti-inflammatory properties** and suppresses acetylcholinesterase activity. Individual ingredients contribute multiple pharmacological effects including promoting hematopoietic function, enhancing immunity, anti-cancer properties, and cardiovascular protection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ren Shen Yang Rong Tang.